Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Mr. Robert Brainin 2021 'den beri şirketle birlikte olan Champions Oncology Inc 'in Chief Executive Officer 'ıdır.
CSBR hissesinin fiyat performansı nasıl?
CSBR 'in mevcut fiyatı $5.85 'dir, son işlem günde 0% azalmış etti.
Champions Oncology Inc için ana iş temaları veya sektörler nelerdir?
Champions Oncology Inc Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
Champions Oncology Inc 'in piyasa değerlemesi nedir?
Champions Oncology Inc 'in mevcut piyasa değerlemesi $81.2M 'dir
Champions Oncology Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist Champions Oncology Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 4 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir